Limestone Investment Advisors »

Vaxcyte shares owned by Limestone Investment Advisors

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Limestone Investment Advisors from 13F filings

Historical chart of Limestone Investment Advisors investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Limestone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Limestone Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $346k 9.6k 36.02

More positions owned by Limestone Investment Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Goldman Sachs Call Option (GS)
JPMorgan Chase & Co. Call Option (JPM)
Citigroup Com New Call Option (C)
Alphabet Cap Stk Cl A (GOOGL)
Asml Holding N V N Y Registry Shs Call Option (ASML)
Netflix (NFLX)
Wells Fargo & Company Call Option (WFC)
Bank of America Corporation Call Option (BAC)
Advanced Micro Devices (AMD)
Costco Wholesale Corporation (COST)

View all positions for Limestone Investment Advisors

Top funds holding Vaxcyte

Henderson Group
FMR
Vanguard Group
RA Capital Management
BlackRock
T. Rowe Price Investment Management
Wellington Management Company
State Street Corporation
D. E. Shaw & Co
Paradigm Biocapital Advisors
Westfield Capital Management Company
Kynam Capital Management
Deep Track Capital
Geode Capital Management
Jpmorgan Chase & Co

View all funds holding Vaxcyte